ERBB2 and breast carcinoma: In a more granular perspective, breast cancer is a heterogeneous disease which is classifiable into several molecular subtypes, including luminal A, luminal B, human epidermal growth factor (EGF) receptor 2 (HER2) overexpressing, and basal-like.